Literature DB >> 18791205

Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.

Yuji Shiba1, Masafumi Takahashi, Takeki Hata, Hideki Murayama, Hajime Morimoto, Hirohiko Ise, Takashi Nagasawa, Uichi Ikeda.   

Abstract

AIMS: The chemokine stromal cell-derived factor-1 (SDF-1) and its receptor (CXCR4, CXC chemokine receptor 4) play a critical role in the process of post-natal neovascularization. Here, we investigated the role of CXCR4(+) bone marrow cells (BMCs) in neovascularization in a murine hindlimb ischaemia model. METHODS AND
RESULTS: We found that the expression of CXCR4 in BMCs was specifically upregulated by cultivation; therefore, we used freshly isolated BMCs and cultivated BMCs, designated as BMC(Fr) and BMC(Cul), respectively. The increased CXCR4 expression corresponded to the migratory capacity in response to SDF-1 alpha. Real-time reverse transcription-polymerase chain reaction and immunohistochemical analyses revealed that SDF-1 alpha expression was significantly increased in the ischaemic limbs of mice. Blood flow perfusion and capillary density were significantly accelerated in mice implanted with BMC(Cul) as compared with those in mice implanted with BMC(Fr). The stimulatory effect of BMC(Cul) on neovascularization was significantly impaired when BMC(Cul) derived from CXCR4(+/-) mice were implanted. The implanted BMC(Cul) showed high retention in the ischaemic limbs. Further, the implantation of BMC(Cul) significantly increased the expression of interleukin (IL)-1 beta and vascular endothelial growth factor-A in the ischaemic limbs.
CONCLUSION: The upregulation of CXCR4 expression by cultivation may serve as a useful source of BMCs for accelerating therapeutic angiogenesis in ischaemic cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791205     DOI: 10.1093/cvr/cvn247

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

1.  Evidence that β7 Integrin Regulates Hematopoietic Stem Cell Homing and Engraftment Through Interaction with MAdCAM-1.

Authors:  Jodi L Murakami; Baohui Xu; Christopher B Franco; Xingbin Hu; Stephen J Galli; Irving L Weissman; Ching-Cheng Chen
Journal:  Stem Cells Dev       Date:  2015-11-05       Impact factor: 3.272

2.  Murine Glucocorticoid Receptors Orchestrate B Cell Migration Selectively between Bone Marrow and Blood.

Authors:  Derek W Cain; Carl D Bortner; David Diaz-Jimenez; Maria G Petrillo; Amanda Gruver-Yates; John A Cidlowski
Journal:  J Immunol       Date:  2020-06-22       Impact factor: 5.422

3.  Targeting N-acetylglucosamine-bearing polymer-coated liposomes to vascular smooth muscle cells.

Authors:  Mamiko Ise; Hirohiko Ise; Yuji Shiba; Satoshi Kobayashi; Mitsuaki Goto; Masafumi Takahashi; Toshihiro Akaike; Uichi Ikeda
Journal:  J Artif Organs       Date:  2011-08-02       Impact factor: 1.731

Review 4.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

5.  CXCR4 Overexpression in Human Adipose Tissue-Derived Stem Cells Improves Homing and Engraftment in an Animal Limb Ischemia Model.

Authors:  MiJung Kim; Dong-Ik Kim; Eun Key Kim; Chan-Wha Kim
Journal:  Cell Transplant       Date:  2016-08-05       Impact factor: 4.064

Review 6.  The Role of SDF-1/CXCR4/CXCR7 in Neuronal Regeneration after Cerebral Ischemia.

Authors:  Xi Cheng; Huibin Wang; Xiuchun Zhang; Shanshan Zhao; Zhike Zhou; Xiaopeng Mu; Chuansheng Zhao; Weiyu Teng
Journal:  Front Neurosci       Date:  2017-10-24       Impact factor: 4.677

7.  VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells.

Authors:  Qiming Li; Shudong Xia; Hanyun Fang; Jiansheng Pan; Yinfeng Jia; Gang Deng
Journal:  Exp Ther Med       Date:  2017-01-02       Impact factor: 2.447

8.  The homing of bone marrow stem cells is differentially activated in ischemic and valvular heart diseases and influenced by beta-blockers.

Authors:  Melissa Kristocheck; Lucinara D Dias; Carine Ghem; Bruna Eibel; Renato A K Kalil; Melissa M Markoski
Journal:  J Transl Med       Date:  2018-05-21       Impact factor: 5.531

9.  FGF23 ameliorates ischemia-reperfusion induced acute kidney injury via modulation of endothelial progenitor cells: targeting SDF-1/CXCR4 signaling.

Authors:  Huang-Ming Chang; Kang-Yung Peng; Chieh-Kai Chan; Chiao-Yin Sun; Ying-Ying Chen; Han-Mei Chang; Chun-Lin Huang; Pei-Chun Liu; Peng-Ying Chen; Kuo-Chuan Wang; Wei-Jie Wang; Chen-Chi Wu; Yu-Feng Lin; Tai-Shuan Lai; Tao-Min Huang; Guang-Huar Young; Shuei-Liong Lin; Marlies Ostermann; Tzong-Shinn Chu; Jeff S Chueh; Vin-Cent Wu
Journal:  Cell Death Dis       Date:  2021-04-17       Impact factor: 8.469

Review 10.  Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium.

Authors:  Daniel I Bromage; Sean M Davidson; Derek M Yellon
Journal:  Pharmacol Ther       Date:  2014-04-01       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.